drugset / Trial / NCT01886781

Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome

NCT01886781

RandomizedParallel-groupDouble-blindTreatment

Summary

In patients with IBS, will supplementation with a probiotic demonstrate symptomatic efficacy and will the probiotic influence gut microflora and thus improve clinical outcomes, as compared to no intervention.

Timeline

Start
2011-01
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus plantarum 299v Other / unclassified 5e+09 unknown